Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 89,954 | 102,875 | -237,892 | -158,239 | -118,598 |
| Depreciation Amortization | 2,694 | 1,507 | 3,791 | 2,728 | 1,829 |
| Accounts receivable | 85,217 | 8,579 | -150,683 | -106,626 | -31,350 |
| Accounts payable and accrued liabilities | 40,077 | 616 | 23,760 | 24,545 | 17,786 |
| Other Working Capital | 62,886 | -11,378 | -34,350 | -43,195 | -15,575 |
| Other Operating Activity | -267,860 | -148,965 | 220,490 | 118,840 | 38,261 |
| Operating Cash Flow | $12,968 | $-46,766 | $-174,884 | $-161,947 | $-107,647 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | 6,997 | 6,997 | N/A |
| Purchase Of Investment | 0 | N/A | -19,507 | -19,507 | -19,507 |
| Sale Of Investment | 14,888 | 14,888 | 157,642 | 121,430 | 78,032 |
| Other Investing Activity | 215,531 | 187,875 | -492 | 517 | 366 |
| Investing Cash Flow | $230,419 | $202,763 | $144,640 | $109,437 | $58,891 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 37,120 | N/A | N/A | N/A | N/A |
| Debt Repayment | -260,387 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,455 | 1,507 | 72,412 | 71,993 | 60,503 |
| Common Stock Repurchased | 685 | N/A | 1,809 | 1,337 | 1,337 |
| Other Financing Activity | 34,089 | -620 | -4,621 | -4,096 | -3,711 |
| Financing Cash Flow | $-187,038 | $887 | $69,600 | $69,234 | $58,129 |
| Beginning Cash Position | 103,343 | 103,343 | 63,987 | 63,987 | 63,987 |
| End Cash Position | 159,692 | 260,227 | 103,343 | 80,711 | 73,360 |
| Net Cash Flow | $56,349 | $156,884 | $39,356 | $16,724 | $9,373 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,968 | -46,766 | -174,884 | -161,947 | -107,647 |
| Free Cash Flow | 12,968 | -46,766 | -174,884 | -161,947 | -107,647 |